Wu, Ziyan https://orcid.org/0000-0002-5243-6899
Li, Haolong
Xu, Honglin
Feng, Futai
Zhang, Fengchun
Zhang, Shulan
Wang, Li
Li, Yongzhe
Funding for this research was provided by:
the National Natural Science Foundation of China Grants (81871302)
the National Natural Science Foundation of China Grants (81801631)
the National Key Research and Development Program of China (2018YFE0207300)
Beijing Municipal Science & Technology Commission (Z211100002521021)
the National High Level Hospital Clinical Research Funding (2022-PUMCH-B-124)
the National High Level Hospital Clinical Research Funding (2022-PUMCH-A-007)
Article History
Received: 22 June 2023
Accepted: 17 August 2023
First Online: 15 September 2023
Declarations
:
: ZW, HL, HX, FF, FZ, SZ, LW, YL declare no conflicts of interest.
: The Ethics Committee of Peking Union Medical College Hospital approved the study protocol (JS-2156).
: The informed consent to participate in the ChIP-seq study was provided by the enrolled 3 PBC patients and 3 healthy controls or their families.